Neuronetics, Inc.

For the period ended Dec 31, 2025. Filed Mar 17, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 17, 2026

STIM$2.18+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(In thousands, except per share data)



· · · Years ended December 31,
· · · 2025 · · 2024 · · 2023
Revenues
Products and Other	$62,180	$70,445	$71,348
Services	86,977	4,445	—
Total Revenue	149,157	74,890	71,348
Cost of revenues
Products and Other	16,464	17,516	19,643
Services	60,385	3,213	—
Total Cost of revenues	76,849	20,729	19,643
Gross profit	72,308	54,161	51,705
Operating expenses:
Sales and marketing	47,458	45,631	47,318
General and administrative	49,702	30,322	25,426
Research and development	6,584	12,771	9,515
Total operating expenses	103,744	88,724	82,259
Loss from operations	(31,436)	(34,563)	(30,554)
Other (income) expense:
Interest expense	8,415	7,286	5,424
Loss on extinguishment of debt	—	4,427	—
Other income, net	(716)	(2,549)	(5,789)
Net loss	$(39,135)	$(43,727)	$(30,189)
Less: Net loss attributable to non-controlling interest	(137)	(19)	—
Net loss attributable to Neuronetics stockholders’	$(38,998)	$(43,708)	$(30,189)
Net loss per share of common stock outstanding, basic and diluted attributable to Neuronetics stockholders’	$(0.59)	$(1.38)	$(1.05)
Weighted average common shares outstanding, basic and diluted	65,951	31,734	28,658

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.